Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Activity) (Details) (Stock Settled Stock Appreciation Rights SARS [Member], USD $) In Thousands, except Per Share data, unless otherwise specified	6 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Stock Settled Stock Appreciation Rights SARS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Rights, Outstanding at beginning of year	358
Number of Rights, Exercised	(43)
Number of Rights, Granted	0	2
Number of Rights, Forfeited	(31)
Number of Rights, Outstanding at end of period	284
Number of Rights, Exercisable and vested at end of period	42
Number of Rights, Vested and expected to vest at end of period	278
Weighted Average Exercise Price, Outstanding at beginning of year	$ 76.75
Weighted Average Exercise Price, Exercised	$ 63.86
Weighted Average Exercise Price, Granted	$ 0.00
Weighted Average Exercise Price, Forfeited	$ 79.42
Weighted Average Exercise Price, Outstanding at end of period	$ 78.40
Weighted Average Exercise Price, Exercisable and vested at end of period	$ 65.66
Weighted Average Exercise Price, Vested and expected to vest at end of period	$ 78.38
Weighted Average Remaining Contractual Life in Years, Outstanding at end of period	3 years 2 months 27 days
Weighted Average Remaining Contractual Life in Years, Exercisable and vested at end of period	1 year 9 months 26 days
Weighted Average Remaining Contractual Life in Years, Vested and expected to vest at end of period	3 years 2 months 27 days
Aggregate Intrinsic Value, Outstanding at end of period	$ 4,325
Aggregate Intrinsic Value, Exercisable and vested at end of period	1,178
Aggregate Intrinsic Value, Vested and expected to vest at end of period	$ 4,236